Adaptive COVID-19 Treatment Trial 2 (ACTT-II)

Condition:   COVID-19 Interventions:   Other: Placebo;   Drug: Remdesivir;   Drug: Baricitinib Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials